Glen Eagle Advisors’s Cidara Therapeutics CDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-5
| Closed | -$520 | – | 714 |
|
|
2018
Q2 | $520 | Hold |
5
| – | – | ﹤0.01% | 673 |
|
|
2018
Q1 | $400 | Hold |
5
| – | – | ﹤0.01% | 669 |
|
|
2017
Q4 | $680 | Hold |
5
| – | – | ﹤0.01% | 620 |
|
|
2017
Q3 | $810 | Hold |
5
| – | – | ﹤0.01% | 616 |
|
|
2017
Q2 | $750 | Hold |
5
| – | – | ﹤0.01% | 570 |
|
|
2017
Q1 | $780 | Sell |
5
-15
| -75% | -$2.34K | ﹤0.01% | 535 |
|
|
2016
Q4 | $4.16K | Buy |
+20
| New | +$4.16K | ﹤0.01% | 455 |
|